Skip Navigation

European Heart Journal 2004 25(14):1187-1196; doi:10.1016/j.ehj.2004.04.026
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Panteghini, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Panteghini, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Review

Role and importance of biochemical markers in clinical cardiology

Mauro Panteghini*

Clinical Chemistry Laboratory 1, Spedali Civili University Hospital, 25125 Brescia, Italy

* Tel.: +39-030-3995470; fax: +39-030-3995369
E-mail address: panteghi{at}bshosp.osp.unibs.it

Received 10 February 2004; revised 1 April 2004; accepted 8 April 2004

Abstract

This paper reviews the current contribution of the biochemical marker determination to clinical cardiology and discusses some important developments in this field. Biochemical markers play a pivotal role in the diagnosis and management of patients with acute coronary syndrome (ACS), as witnessed by the incorporation of cardiac troponins into new international guidelines for patients with ACS and in the re-definition of myocardial infarction. Despite the success of cardiac troponins, there is still a need for the development of early markers that can reliably rule out ACS from the emergency room at presentation and also detect myocardial ischaemia in the absence of irreversible myocyte injury. Under investigation are two classes of indicators: markers of early injury/ischaemia and markers of inflammation and coronary plaque instability and disruption. Finally, with the characterisation of the cardiac natriuretic peptides, Laboratory Medicine is also assuming a role in the assessment of cardiac function.

Key Words: Biological markers • Diagnosis • Myocardial infarction • Troponin


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Toxicol PatholHome page
M. York, C. Scudamore, S. Brady, C. Chen, S. Wilson, M. Curtis, G. Evans, W. Griffiths, M. Whayman, T. Williams, et al.
Characterization of Troponin Responses in Isoproterenol-Induced Cardiac Injury in the Hanover Wistar Rat
Toxicol Pathol, June 1, 2007; 35(4): 606 - 617.
[Abstract] [PDF]

Home page
 QJMHome page
P. Mad, H. Domanovits, C. Fazelnia, K. Stiassny, G. Russmuller, A. Cseh, G. Sodeck, T. Binder, G. Christ, T. Szekeres, et al.
Human heart-type fatty-acid-binding protein as a point-of-care test in the early diagnosis of acute myocardial infarction
QJM, April 1, 2007; 100(4): 203 - 210.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
J. A. Laukkanen, S. Kurl, M. Ala-Kopsala, O. Vuolteenaho, H. Ruskoaho, K. Nyyssonen, and J. T. Salonen
Plasma N-terminal fragments of natriuretic propeptides predict the risk of cardiovascular events and mortality in middle-aged men
Eur. Heart J., May 2, 2006; 27(10): 1230 - 1237.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. James, M. Flodin, N. Johnston, B. Lindahl, and P. Venge
The Antibody Configurations of Cardiac Troponin I Assays May Determine Their Clinical Performance
Clin. Chem., May 1, 2006; 52(5): 832 - 837.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
S. Kilickap, I. Barista, and K. Aytemir
Reply to "Troponins in prediction of cardiotoxic effects", by D. Cardinale et al.
Ann. Onc., January 1, 2006; 17(1): 173 - 174.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Panteghini
Standardization of Cardiac Troponin I Measurements: The Way Forward?
Clin. Chem., September 1, 2005; 51(9): 1594 - 1597.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.